Litcius/Paper detail

Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft

Sisi Liu, Junwen Zhang, Sheng Fang, Xiaodong Su, Qing Zhang, Gui‐Dong Zhu, Li Zhu, Mingwei Zhao, Fusheng Liu

2020Cancer Letters15 citationsDOI

Topics & Concepts

Oncolytic virusCancer researchHerpes simplex virusIn vivoDihydropyrimidine dehydrogenaseMelanomaBiologyMedicineVirusImmunologyChemotherapyFluorouracilInternal medicineTumor cellsBiotechnologyThymidylate synthaseVirus-based gene therapy researchImmunotherapy and Immune ResponsesOcular Oncology and Treatments
Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft | Litcius